Literature DB >> 1551635

Effect of duration of hepatitis B virus infection on the association between human immunodeficiency virus type-1 and hepatitis B viral replication.

B A Koblin1, P E Taylor, P Rubinstein, C E Stevens.   

Abstract

This study examined the effect of duration of hepatitis B virus infection on the association between human immunodeficiency virus type-1 infection and hepatitis B viral replication. Twenty-five chronic HBsAg carriers were studied. Presence of hepatitis B virus DNA and expression of HBeAg were more frequent among 20 chronic HBsAg carriers positive for human immunodeficiency virus type-1 antibody compared with five chronic HBsAg carriers negative for human immunodeficiency virus type-1 antibody, but the associations were not statistically significant. Hepatitis B virus DNA and HBeAg were inversely related to duration of hepatitis B virus infection (p less than 0.001). Stratifying for duration of hepatitis B virus infection, the presence of viral replication was similar among patients negative and positive for antibody to human immunodeficiency virus type-1. Hepatitis B virus DNA levels did not increase with the decline of cellular immunity over time. In conclusion, hepatitis B virus replication among chronic carriers may be a function of duration of hepatitis B virus infection rather than of an effect of human immunodeficiency virus type-1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1551635     DOI: 10.1002/hep.1840150406

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  5 in total

1.  Parasite interactions in natural populations: insights from longitudinal data.

Authors:  S Telfer; R Birtles; M Bennett; X Lambin; S Paterson; M Begon
Journal:  Parasitology       Date:  2008-05-12       Impact factor: 3.234

2.  Hepatitis B virus-human immunodeficiency virus co-infection in France: a cross-sectional multicentre study.

Authors:  D Sène; S Pol; L Piroth; C Goujard; P Dellamonica; J Moussali; D Rey; V Loustaud-Ratti; L Alric; M Chousterman; F Borsa-Lebas; O Boucher; D Séréni; P Cacoub
Journal:  Epidemiol Infect       Date:  2006-07-25       Impact factor: 2.451

Review 3.  Management of hepatitis B in patients coinfected with the human immunodeficiency virus.

Authors:  R Lessells; C Leen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-04-27       Impact factor: 3.267

4.  Sustained elimination of hepatitis B virus from serum induced in a patient with chronic hepatitis B and advanced human immunodeficiency virus infection.

Authors:  T Wölfel; P Schirmacher; J Schlaak; P Knolle; H P Dienes; W Dippold; K H Meyer zum Büschenfelde; G Gerken
Journal:  Clin Investig       Date:  1994-12

5.  Randomized controlled trial of Hepatitis B virus vaccine in HIV-1-infected patients comparing two different doses.

Authors:  Patricia Cornejo-Juárez; Patricia Volkow-Fernández; Luis Enrique Soto-Ramírez; Kenia Escobedo-López; Diana Vilar-Compte; Guillermo Ruiz-Palacios
Journal:  AIDS Res Ther       Date:  2006-04-06       Impact factor: 2.250

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.